Neglected Tropical Diseases Drugs and Vaccine Market, Global Outlook and Forecast 2022-2028

April 2022 | 62 pages | ID: N25E24AC454EEN
Market Monitor Global

Abstracts

Neglected tropical diseases (NTDs) are a diverse group of tropical infections which are common in low-income populations in developing regions of Africa, Asia, and the Americas. They are caused by a variety of pathogens such as viruses, bacteria, protozoa and helminths.

This report contains market size and forecasts of Neglected Tropical Diseases Drugs and Vaccine in Global, including the following market information:

Global Neglected Tropical Diseases Drugs and Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Neglected Tropical Diseases Drugs and Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Malaria Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Neglected Tropical Diseases Drugs and Vaccine include Artecef BV, GlaxoSmithKline, AstraZeneca, Novartis, Sanofi-Aventis, Ranbaxy Labs, Lupin, Macleods Pharmaceuticals and Cipla, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neglected Tropical Diseases Drugs and Vaccine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Neglected Tropical Diseases Drugs and Vaccine Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Neglected Tropical Diseases Drugs and Vaccine Market Segment Percentages, by Type, 2021 (%)

• Malaria
• Ebola
• Dengue
• Chagas
• Leishmaniasis
• Other

Global Neglected Tropical Diseases Drugs and Vaccine Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Neglected Tropical Diseases Drugs and Vaccine Market Segment Percentages, by Application, 2021 (%)

• Drugs
• Vaccines

Global Neglected Tropical Diseases Drugs and Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Neglected Tropical Diseases Drugs and Vaccine Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Neglected Tropical Diseases Drugs and Vaccine revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Neglected Tropical Diseases Drugs and Vaccine revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Artecef BV
• GlaxoSmithKline
• AstraZeneca
• Novartis
• Sanofi-Aventis
• Ranbaxy Labs
• Lupin
• Macleods Pharmaceuticals
• Cipla
• Romark Laboratories
• Toyama Chemica

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Neglected Tropical Diseases Drugs and Vaccine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NEGLECTED TROPICAL DISEASES DRUGS AND VACCINE OVERALL MARKET SIZE

2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size: 2021 VS 2028
2.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Neglected Tropical Diseases Drugs and Vaccine Players in Global Market
3.2 Top Global Neglected Tropical Diseases Drugs and Vaccine Companies Ranked by Revenue
3.3 Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Companies
3.4 Top 3 and Top 5 Neglected Tropical Diseases Drugs and Vaccine Companies in Global Market, by Revenue in 2021
3.5 Global Companies Neglected Tropical Diseases Drugs and Vaccine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neglected Tropical Diseases Drugs and Vaccine Players in Global Market
  3.6.1 List of Global Tier 1 Neglected Tropical Diseases Drugs and Vaccine Companies
  3.6.2 List of Global Tier 2 and Tier 3 Neglected Tropical Diseases Drugs and Vaccine Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Neglected Tropical Diseases Drugs and Vaccine Market Size Markets, 2021 & 2028
  4.1.2 Malaria
  4.1.3 Ebola
  4.1.4 Dengue
  4.1.5 Chagas
  4.1.6 Leishmaniasis
  4.1.7 Other
4.2 By Type - Global Neglected Tropical Diseases Drugs and Vaccine Revenue & Forecasts
  4.2.1 By Type - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2017-2022
  4.2.2 By Type - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2023-2028
  4.2.3 By Type - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Neglected Tropical Diseases Drugs and Vaccine Market Size, 2021 & 2028
  5.1.2 Drugs
  5.1.3 Vaccines
5.2 By Application - Global Neglected Tropical Diseases Drugs and Vaccine Revenue & Forecasts
  5.2.1 By Application - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2017-2022
  5.2.2 By Application - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2023-2028
  5.2.3 By Application - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Neglected Tropical Diseases Drugs and Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue & Forecasts
  6.2.1 By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2017-2022
  6.2.2 By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2023-2028
  6.2.3 By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Neglected Tropical Diseases Drugs and Vaccine Revenue, 2017-2028
  6.3.2 US Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
  6.3.3 Canada Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
  6.3.4 Mexico Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Neglected Tropical Diseases Drugs and Vaccine Revenue, 2017-2028
  6.4.2 Germany Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
  6.4.3 France Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
  6.4.4 U.K. Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
  6.4.5 Italy Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
  6.4.6 Russia Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
  6.4.7 Nordic Countries Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
  6.4.8 Benelux Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Neglected Tropical Diseases Drugs and Vaccine Revenue, 2017-2028
  6.5.2 China Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
  6.5.3 Japan Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
  6.5.4 South Korea Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
  6.5.5 Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
  6.5.6 India Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Neglected Tropical Diseases Drugs and Vaccine Revenue, 2017-2028
  6.6.2 Brazil Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
  6.6.3 Argentina Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Revenue, 2017-2028
  6.7.2 Turkey Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
  6.7.3 Israel Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
  6.7.4 Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028
  6.7.5 UAE Neglected Tropical Diseases Drugs and Vaccine Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Artecef BV
  7.1.1 Artecef BV Corporate Summary
  7.1.2 Artecef BV Business Overview
  7.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
  7.1.4 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2017-2022)
  7.1.5 Artecef BV Key News
7.2 GlaxoSmithKline
  7.2.1 GlaxoSmithKline Corporate Summary
  7.2.2 GlaxoSmithKline Business Overview
  7.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
  7.2.4 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2017-2022)
  7.2.5 GlaxoSmithKline Key News
7.3 AstraZeneca
  7.3.1 AstraZeneca Corporate Summary
  7.3.2 AstraZeneca Business Overview
  7.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
  7.3.4 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2017-2022)
  7.3.5 AstraZeneca Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
  7.4.4 Novartis Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2017-2022)
  7.4.5 Novartis Key News
7.5 Sanofi-Aventis
  7.5.1 Sanofi-Aventis Corporate Summary
  7.5.2 Sanofi-Aventis Business Overview
  7.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
  7.5.4 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2017-2022)
  7.5.5 Sanofi-Aventis Key News
7.6 Ranbaxy Labs
  7.6.1 Ranbaxy Labs Corporate Summary
  7.6.2 Ranbaxy Labs Business Overview
  7.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
  7.6.4 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2017-2022)
  7.6.5 Ranbaxy Labs Key News
7.7 Lupin
  7.7.1 Lupin Corporate Summary
  7.7.2 Lupin Business Overview
  7.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
  7.7.4 Lupin Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2017-2022)
  7.7.5 Lupin Key News
7.8 Macleods Pharmaceuticals
  7.8.1 Macleods Pharmaceuticals Corporate Summary
  7.8.2 Macleods Pharmaceuticals Business Overview
  7.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
  7.8.4 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2017-2022)
  7.8.5 Macleods Pharmaceuticals Key News
7.9 Cipla
  7.9.1 Cipla Corporate Summary
  7.9.2 Cipla Business Overview
  7.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
  7.9.4 Cipla Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2017-2022)
  7.9.5 Cipla Key News
7.10 Romark Laboratories
  7.10.1 Romark Laboratories Corporate Summary
  7.10.2 Romark Laboratories Business Overview
  7.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
  7.10.4 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2017-2022)
  7.10.5 Romark Laboratories Key News
7.11 Toyama Chemica
  7.11.1 Toyama Chemica Corporate Summary
  7.11.2 Toyama Chemica Business Overview
  7.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Major Product Offerings
  7.11.4 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Revenue in Global Market (2017-2022)
  7.11.5 Toyama Chemica Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Neglected Tropical Diseases Drugs and Vaccine Market Opportunities & Trends in Global Market
Table 2. Neglected Tropical Diseases Drugs and Vaccine Market Drivers in Global Market
Table 3. Neglected Tropical Diseases Drugs and Vaccine Market Restraints in Global Market
Table 4. Key Players of Neglected Tropical Diseases Drugs and Vaccine in Global Market
Table 5. Top Neglected Tropical Diseases Drugs and Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Share by Companies, 2017-2022
Table 8. Global Companies Neglected Tropical Diseases Drugs and Vaccine Product Type
Table 9. List of Global Tier 1 Neglected Tropical Diseases Drugs and Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neglected Tropical Diseases Drugs and Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Neglected Tropical Diseases Drugs and Vaccine Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Neglected Tropical Diseases Drugs and Vaccine Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Neglected Tropical Diseases Drugs and Vaccine Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Neglected Tropical Diseases Drugs and Vaccine Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2023-2028
Table 30. Artecef BV Corporate Summary
Table 31. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 32. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn), (2017-2022)
Table 33. GlaxoSmithKline Corporate Summary
Table 34. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 35. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn), (2017-2022)
Table 36. AstraZeneca Corporate Summary
Table 37. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 38. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 41. Novartis Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi-Aventis Corporate Summary
Table 43. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 44. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn), (2017-2022)
Table 45. Ranbaxy Labs Corporate Summary
Table 46. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 47. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn), (2017-2022)
Table 48. Lupin Corporate Summary
Table 49. Lupin Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 50. Lupin Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn), (2017-2022)
Table 51. Macleods Pharmaceuticals Corporate Summary
Table 52. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 53. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn), (2017-2022)
Table 54. Cipla Corporate Summary
Table 55. Cipla Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 56. Cipla Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn), (2017-2022)
Table 57. Romark Laboratories Corporate Summary
Table 58. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 59. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn), (2017-2022)
Table 60. Toyama Chemica Corporate Summary
Table 61. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Offerings
Table 62. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Neglected Tropical Diseases Drugs and Vaccine Segment by Type in 2021
Figure 2. Neglected Tropical Diseases Drugs and Vaccine Segment by Application in 2021
Figure 3. Global Neglected Tropical Diseases Drugs and Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Neglected Tropical Diseases Drugs and Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Neglected Tropical Diseases Drugs and Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2021
Figure 8. By Type - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2017-2028
Figure 9. By Application - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2017-2028
Figure 10. By Region - Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2017-2028
Figure 11. By Country - North America Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2017-2028
Figure 12. US Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2017-2028
Figure 16. Germany Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2028
Figure 17. France Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2017-2028
Figure 24. China Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. India Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2017-2028
Figure 30. Brazil Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share, 2017-2028
Figure 33. Turkey Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Neglected Tropical Diseases Drugs and Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Lupin Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Cipla Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)